Ligand id: 6880

Name: daclizumab

View interactive charts of activity data from ChEMBL and GtoPdb across species (New!)

Bioactivity Comments
Peptide sequence analysis of the heavy chain variable region of daclizumab provides a match with patented sequence from US5693761 [2].
Selectivity at Human catalytic receptors
Key to terms and symbols Click column headers to sort
Target Type Action Affinity Units Concentration range (M) Reference
Interleukin-2 receptor subunit α Antibody Binding >8.0 pKd - 2
pKd >8.0 (Kd <1x10-8 M) [2]